Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 mass balance and metabolite profiling study of single-dose pritelivir
NL-OMON50254Phase 1Active, not recruiting
- Sponsor
- AiCuris
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pritelivir in herpes simplex (HSV), sponsored by AiCuris. Primary endpoints: Mass balance of pritelivir, Metabolite profiling and identification and 4 more. Started Oct 2021; status: active, not recruiting.
02
Drugs
pritelivir
03
Conditions
herpes simplex (HSV)
Beyond the preview
Go deeper on NL-OMON50254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50254.